Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Liver Transplant
Phase of Trial: Phase IV
Latest Information Update: 03 Apr 2018
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 28 Mar 2018 Status changed from not yet recruiting to recruiting.
- 04 Oct 2017 Planned initiation date changed from 1 Sep 2017 to 31 Dec 2017.
- 07 Jul 2017 New trial record